Rushmore Investment Advisors’s Allergan Inc AGN Stock Holding History

Rushmore Investment Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$2.28M	Buy	+27,113	New	+$2.81M	0.46%	63

Other funds holding AGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rushmore Investment Advisors's AGN Position: Q2 2013 in Review

Rushmore Investment Advisors opened a new position in Allergan Inc (AGN) in Q2 2013: 27,113 shares worth $2.28M. The stake represents 0.46% of the portfolio and ranks #63 among its holdings.

648 funds tracked by Wall St. Rank hold AGN as of Q2 2013.

Rushmore Investment Advisors held 27,113 shares of Allergan Inc worth $2.28M as of Q2 2013.
Allergan Inc was a new Rushmore Investment Advisors position in Q2 2013.
Allergan Inc made up 0.46% of Rushmore Investment Advisors's portfolio in Q2 2013, its #63 holding.
648 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2013.

Based on Rushmore Investment Advisors's 13F filing for Q2 2013, filed 29 Aug 2013.